JP2000516589A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516589A5
JP2000516589A5 JP1998508453A JP50845398A JP2000516589A5 JP 2000516589 A5 JP2000516589 A5 JP 2000516589A5 JP 1998508453 A JP1998508453 A JP 1998508453A JP 50845398 A JP50845398 A JP 50845398A JP 2000516589 A5 JP2000516589 A5 JP 2000516589A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998508453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516589A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1997/003889 external-priority patent/WO1998004552A1/en
Publication of JP2000516589A publication Critical patent/JP2000516589A/ja
Publication of JP2000516589A5 publication Critical patent/JP2000516589A5/ja
Ceased legal-status Critical Current

Links

JP10508453A 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド Ceased JP2000516589A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
US60/022,079 1996-07-29
PCT/EP1997/003889 WO1998004552A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
JP2000516589A JP2000516589A (ja) 2000-12-12
JP2000516589A5 true JP2000516589A5 (cg-RX-API-DMAC7.html) 2005-03-10

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10508453A Ceased JP2000516589A (ja) 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド

Country Status (23)

Country Link
US (2) US5856517A (cg-RX-API-DMAC7.html)
EP (1) EP0915872B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000516589A (cg-RX-API-DMAC7.html)
KR (1) KR20000029637A (cg-RX-API-DMAC7.html)
CN (2) CN1151149C (cg-RX-API-DMAC7.html)
AR (1) AR008267A1 (cg-RX-API-DMAC7.html)
AT (1) ATE240318T1 (cg-RX-API-DMAC7.html)
AU (1) AU739742B2 (cg-RX-API-DMAC7.html)
BR (1) BR9711605A (cg-RX-API-DMAC7.html)
CA (1) CA2262092A1 (cg-RX-API-DMAC7.html)
CO (1) CO4900055A1 (cg-RX-API-DMAC7.html)
CY (1) CY2483B1 (cg-RX-API-DMAC7.html)
DE (1) DE69722003T2 (cg-RX-API-DMAC7.html)
DK (1) DK0915872T3 (cg-RX-API-DMAC7.html)
ES (1) ES2198001T3 (cg-RX-API-DMAC7.html)
HR (1) HRP970414A2 (cg-RX-API-DMAC7.html)
MA (1) MA24287A1 (cg-RX-API-DMAC7.html)
PE (1) PE91698A1 (cg-RX-API-DMAC7.html)
PT (1) PT915872E (cg-RX-API-DMAC7.html)
SA (1) SA97180473A (cg-RX-API-DMAC7.html)
TR (1) TR199900157T2 (cg-RX-API-DMAC7.html)
WO (1) WO1998004552A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA976492B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002580T2 (tr) * 1998-03-17 2000-11-21 F.Hoffmann-La Roche Ag Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
WO2001044247A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
ATE267194T1 (de) * 1999-12-16 2004-06-15 Lilly Co Eli Medikamente geeignet zur behandlung von proliferativen erkrankungen
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
SI1846406T1 (sl) 2005-02-09 2011-02-28 Arqule Inc Maleimidni derivati, farmacevtski sestavki in postopki za zdravljenje raka
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
US8232285B2 (en) 2007-06-22 2012-07-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
CA2690799C (en) 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US8513292B2 (en) 2007-06-22 2013-08-20 Arqule, Inc. Compositions and methods for the treatment of cancer
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The N−置換アニリン誘導体及び1−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムInserm 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
AU2018290225A1 (en) * 2017-06-21 2020-01-23 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
WO1993018765A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC7.html)
JP2000501771A5 (cg-RX-API-DMAC7.html)
JP2000501599A5 (cg-RX-API-DMAC7.html)
JP2000501018A5 (cg-RX-API-DMAC7.html)
JP2000500076A5 (cg-RX-API-DMAC7.html)
JP2000501324A5 (cg-RX-API-DMAC7.html)
JP2000500055A5 (cg-RX-API-DMAC7.html)
JP2000500026A5 (cg-RX-API-DMAC7.html)
JP2000502472A5 (cg-RX-API-DMAC7.html)
JP2000501338A5 (cg-RX-API-DMAC7.html)
JP2000501825A5 (cg-RX-API-DMAC7.html)
JP2000500874A5 (cg-RX-API-DMAC7.html)
JP2000502425A5 (cg-RX-API-DMAC7.html)
JP2000502485A5 (cg-RX-API-DMAC7.html)
JP2000502568A5 (cg-RX-API-DMAC7.html)
JP2000501774A5 (cg-RX-API-DMAC7.html)
JP2000500912A5 (cg-RX-API-DMAC7.html)
JP2000502570A5 (cg-RX-API-DMAC7.html)
JP2000501876A5 (cg-RX-API-DMAC7.html)
JP2000501744A5 (cg-RX-API-DMAC7.html)
JP2000501229A5 (cg-RX-API-DMAC7.html)
JP2000502316A5 (cg-RX-API-DMAC7.html)
JP2000500857A5 (cg-RX-API-DMAC7.html)
JP2000502714A5 (cg-RX-API-DMAC7.html)
JP2000501569A5 (cg-RX-API-DMAC7.html)